These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30354114)

  • 21. Non-canonical modulators of nuclear receptors.
    Tice CM; Zheng YJ
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4157-64. PubMed ID: 27503683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear receptors: decoding metabolic disease.
    Sonoda J; Pei L; Evans RM
    FEBS Lett; 2008 Jan; 582(1):2-9. PubMed ID: 18023286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of ligands and activation of transcription by nuclear receptors.
    Steinmetz AC; Renaud JP; Moras D
    Annu Rev Biophys Biomol Struct; 2001; 30():329-59. PubMed ID: 11340063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diversity of Quaternary Structures Regulates Nuclear Receptor Activities.
    Fuentes-Prior P; Rojas A; Hagler AT; Estébanez-Perpiñá E
    Trends Biochem Sci; 2019 Jan; 44(1):2-6. PubMed ID: 30293659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The nuclear receptor superfamily: A structural perspective.
    Weikum ER; Liu X; Ortlund EA
    Protein Sci; 2018 Nov; 27(11):1876-1892. PubMed ID: 30109749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators.
    Huang N; vom Baur E; Garnier JM; Lerouge T; Vonesch JL; Lutz Y; Chambon P; Losson R
    EMBO J; 1998 Jun; 17(12):3398-412. PubMed ID: 9628876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sweet dreams for LXR.
    Lazar MA; Willson TM
    Cell Metab; 2007 Mar; 5(3):159-61. PubMed ID: 17339022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design.
    Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural overview and perspectives of the nuclear receptors, a major family as the direct targets for small-molecule drugs.
    Li F; Song C; Zhang Y; Wu D
    Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(1):12-24. PubMed ID: 35130630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical analyses of nuclear receptor-dependent transcription with chromatin templates.
    Ruhl DD; Kraus WL
    Prog Mol Biol Transl Sci; 2009; 87():137-92. PubMed ID: 20374704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diversity and function of orphan nuclear receptors in nematodes.
    Van Gilst M; Gissendanner CR; Sluder AE
    Crit Rev Eukaryot Gene Expr; 2002; 12(1):65-88. PubMed ID: 12433066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A high-throughput, computational system to predict if environmental contaminants can bind to human nuclear receptors.
    Wang X; Zhang X; Xia P; Zhang J; Wang Y; Zhang R; Giesy JP; Shi W; Yu H
    Sci Total Environ; 2017 Jan; 576():609-616. PubMed ID: 27810749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive assessment of NR ligand polypharmacology by a multiplex reporter NR assay.
    Medvedev A; Moeser M; Medvedeva L; Martsen E; Granick A; Raines L; Gorman K; Lin B; Zeng M; Houck KA; Makarov SS
    Sci Rep; 2022 Feb; 12(1):3115. PubMed ID: 35210493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computer-assisted generation of a protein-interaction database for nuclear receptors.
    Albert S; Gaudan S; Knigge H; Raetsch A; Delgado A; Huhse B; Kirsch H; Albers M; Rebholz-Schuhmann D; Koegl M
    Mol Endocrinol; 2003 Aug; 17(8):1555-67. PubMed ID: 12738764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile.
    Moya M; Gómez-Lechón MJ; Castell JV; Jover R
    Chem Biol Interact; 2010 Mar; 184(3):376-87. PubMed ID: 20079722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NURBS: a database of experimental and predicted nuclear receptor binding sites of mouse.
    Fang Y; Liu HX; Zhang N; Guo GL; Wan YJ; Fang J
    Bioinformatics; 2013 Jan; 29(2):295-7. PubMed ID: 23196988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. iDrug-Target: predicting the interactions between drug compounds and target proteins in cellular networking via benchmark dataset optimization approach.
    Xiao X; Min JL; Lin WZ; Liu Z; Cheng X; Chou KC
    J Biomol Struct Dyn; 2015; 33(10):2221-33. PubMed ID: 25513722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antagonist- and inverse agonist-driven interactions of the vitamin D receptor and the constitutive androstane receptor with corepressor protein.
    Lempiäinen H; Molnár F; Macias Gonzalez M; Peräkylä M; Carlberg C
    Mol Endocrinol; 2005 Sep; 19(9):2258-72. PubMed ID: 15905360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advantages of cell-based high-volume screening assays to assess nuclear receptor activation during drug discovery.
    Pinne M; Raucy JL
    Expert Opin Drug Discov; 2014 Jun; 9(6):669-86. PubMed ID: 24819724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of a novel subfamily of nuclear receptors with members that each contain two DNA binding domains.
    Wu W; Niles EG; Hirai H; LoVerde PT
    BMC Evol Biol; 2007 Feb; 7():27. PubMed ID: 17319953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.